Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keeton

Showing results (521-530 of 547) with videos related to

Pageof 55
Sort By:
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivityNtombi S B Benede, Marius B Tincho, Avril Walters, et al.
Science Immunology|January 9, 2026
Mycobacterial α-glucans hijack dectin-1 to facilitate intracellular bacterial survivalShota Torigoe, Sumayah Salie, Roanne Keeton, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Plos Pathogens|November 9, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|February 8, 2023
Importance of conserving large and old trees to continuity of tree-related microhabitatsDaniel Kozák, Marek Svitok, Veronika Zemlerová, et al.
Data in Brief|September 5, 2024
Parameters of 150 temperate and boreal tree species and provenances for an individual-based forest landscape and disturbance modelDominik Thom, Werner Rammer, Katharina Albrich, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal AdenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
NPJ Vaccines|August 12, 2023
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cellsRobert G E Krause, Thandeka Moyo-Gwete, Simone I Richardson, et al.
The Lancet. HIV|February 14, 2026
Safety and immunogenicity of a single dose of Ad26.COV2.S, BNT162b2, or SARS-CoV-2-rS-protein-nanoparticle in previously vaccinated and unvaccinated adults living with and without HIV in South Africa: a phase 2a randomised, observer-blind trialVaneshree Govender, Tarylee Reddy, Pholo Maenetje, et al.
Pageof 55

Showing results (521-530 of 547) with videos related to

Sort By:
Pageof 55
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivityNtombi S B Benede, Marius B Tincho, Avril Walters, et al.
Science Immunology|January 9, 2026
Mycobacterial α-glucans hijack dectin-1 to facilitate intracellular bacterial survivalShota Torigoe, Sumayah Salie, Roanne Keeton, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Plos Pathogens|November 9, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|February 8, 2023
Importance of conserving large and old trees to continuity of tree-related microhabitatsDaniel Kozák, Marek Svitok, Veronika Zemlerová, et al.
Data in Brief|September 5, 2024
Parameters of 150 temperate and boreal tree species and provenances for an individual-based forest landscape and disturbance modelDominik Thom, Werner Rammer, Katharina Albrich, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal AdenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
NPJ Vaccines|August 12, 2023
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cellsRobert G E Krause, Thandeka Moyo-Gwete, Simone I Richardson, et al.
The Lancet. HIV|February 14, 2026
Safety and immunogenicity of a single dose of Ad26.COV2.S, BNT162b2, or SARS-CoV-2-rS-protein-nanoparticle in previously vaccinated and unvaccinated adults living with and without HIV in South Africa: a phase 2a randomised, observer-blind trialVaneshree Govender, Tarylee Reddy, Pholo Maenetje, et al.
Pageof 55